Literature DB >> 14963367

From bone biology to bone analysis.

E Schoenau1, G Saggese, F Peter, G I Baroncelli, N J Shaw, N J Crabtree, Z Zadik, C M Neu, C Noordam, G Radetti, Z Hochberg.   

Abstract

Bone development is one of the key processes characterizing childhood and adolescence. Understanding this process is not only important for physicians treating pediatric bone disorders, but also for clinicians and researchers dealing with postmenopausal and senile osteoporosis. Bone densitometry has great potential to enhance our understanding of bone development. The usefulness of densitometry in children and adolescents would be increased if the physiological mechanisms and structural features of bone were given more consideration in the design and interpretation of densitometric studies. This review gives an overview on the most relevant techniques of quantitative noninvasive bone analysis. Furthermore it describes the relationship between bone biology, selected surrogates describing the biological processes and the possibilities of measuring these surrogates specifically and precisely by the different devices. The overall recommendation for researchers in this field is to describe firstly the biological process to be analyzed (bone growth in length, remodeling or modeling, or all together), secondly the bone parameter which describes this process, and thirdly the reason for selecting a special device. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14963367     DOI: 10.1159/000076635

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  15 in total

Review 1.  Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Authors:  Johannes Roth; Susanne Bechtold; Gudrun Borte; Frank Dressler; Hermann J Girschick; Michael Borte
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

2.  Family-based association study of ROR2 polymorphisms with an array of radiographic hand bone strength phenotypes.

Authors:  S Ermakov; I Malkin; M Keter; E Kobyliansky; G Livshits
Journal:  Osteoporos Int       Date:  2007-07-10       Impact factor: 4.507

Review 3.  Osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Marina Kunstreich; Sebastian Kummer; Hans-Juergen Laws; Arndt Borkhardt; Michaela Kuhlen
Journal:  Haematologica       Date:  2016-10-14       Impact factor: 9.941

Review 4.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

5.  Reduced bone cortical thickness in boys with autism or autism spectrum disorder.

Authors:  Mary L Hediger; Lucinda J England; Cynthia A Molloy; Kai F Yu; Patricia Manning-Courtney; James L Mills
Journal:  J Autism Dev Disord       Date:  2008-05

6.  Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers.

Authors:  M T Saha; H Sievänen; M K Salo; S Tulokas; H H Saha
Journal:  Osteoporos Int       Date:  2008-12-13       Impact factor: 4.507

Review 7.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

8.  [Diagnosis, prophylaxis and therapy of osteoporosis in juvenile idiopathic arthritis: consensus statement of the German Association for Pediatric Rheumatology].

Authors:  J Roth; S Bechtold; G Borte; F Dressler; H Girschick; M Borte
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372

Review 9.  Methods for measurement of pediatric bone.

Authors:  Teresa L Binkley; Ryan Berry; Bonny L Specker
Journal:  Rev Endocr Metab Disord       Date:  2008-02-05       Impact factor: 6.514

10.  1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function.

Authors:  Anna Idelevich; Michael Kerschnitzki; Ron Shahar; Efrat Monsonego-Ornan
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.